The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy
INTRODUCTION[|]Antibodies against the phospholipase A2 receptor (PLA2R) on podocyte membranes result in the formation of immune complexes that cause loss of function of the glomerular basement membrane in primary membranous nephropathy (PMN). It has also been demonstrated that there is a deposition...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2020-06-01
|
Series: | Southern Clinics of Istanbul Eurasia |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-16056 |
id |
doaj-af98d1e30c74446689c886179efe5b33 |
---|---|
record_format |
Article |
spelling |
doaj-af98d1e30c74446689c886179efe5b332021-01-24T18:11:54ZengKARE PublishingSouthern Clinics of Istanbul Eurasia2587-09982020-06-0131210110610.14744/scie.2019.16056SCIE-16056The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous NephropathyDeniz Filinte0Hakkı Arıkan1Mehmet Koç2Handan Kaya3İshak Çetin Özener4Gamze Akbaş5Department of Pathology Marmara University Faculty of Medicine, İstanbul, TurkeyDepartment of Nephrology, Marmara University Faculty of Medicine, İstanbul, TurkeyDepartment of Nephrology, Marmara University Faculty of Medicine, İstanbul, TurkeyDepartment of Pathology Marmara University Faculty of Medicine, İstanbul, TurkeyDepartment of Nephrology, Marmara University Faculty of Medicine, İstanbul, TurkeyDepartment of Pathology Marmara University Faculty of Medicine, İstanbul, TurkeyINTRODUCTION[|]Antibodies against the phospholipase A2 receptor (PLA2R) on podocyte membranes result in the formation of immune complexes that cause loss of function of the glomerular basement membrane in primary membranous nephropathy (PMN). It has also been demonstrated that there is a deposition of complement 4d (C4d) in the glomeruli in PMN. The present study aims to evaluate PLA2R and C4d immunoexpressions in PMN cases and search the correlation with the clinical parameters.[¤]METHODS[|]In this study, clinicopathological data and paraffin-embedded specimens were collected from 51 patients. The formalin-fixed paraffin-embedded tissues were stained using routine hematoxylin-eosin, periodic acid-Schiff, and silver methenamine stains and immunostained for anti-PLA2R and C4d. Ten normal kidney tissues and 10 focal segmental glomerulosclerosis (FSGS) cases were selected as controls for PLA2R and C4d immunoexpression.[¤]RESULTS[|]Of the PMN cases, 51 (100%) cases were positive for PLA2R, including 15 (29%) cases that scored 2+, and 36 (71%) cases that scored 3+. Forty of the 51 cases (78%) were positive for C4d. The percentages of cases staining positively for C4d, per scoring group, were as follows: 31 (61%) cases faintly (1+) positive and 9 (18%) cases moderately (2+) positive. No strong positivity was observed. All of the control cases (100%) were negative for PLA2R and C4d. There was no statistically significant difference between the intensity of the staining of PLA2R and the staining of C4d, proteinuria levels, creatinine levels, and complement 3 (C3) positivity. Similarly, there was no statistically significant difference between the intensity of the staining of C4d and proteinuria levels, creatinine levels, and C3 positivity. [¤]DISCUSSION AND CONCLUSION[|]Immunohistochemical detection of PLA2R and C4d is a safe and easy method for the diagnosis of PMN. In cases where fresh tissue is not available for the detection of IgG and C3 using the immunofluorescence method, positivity for PLA2R and C4d with immunohistochemistry may be beneficial for the diagnosis of PMN.[¤]https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-16056c4dpla2r; primary membranous nephropathy; proteinuria. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Deniz Filinte Hakkı Arıkan Mehmet Koç Handan Kaya İshak Çetin Özener Gamze Akbaş |
spellingShingle |
Deniz Filinte Hakkı Arıkan Mehmet Koç Handan Kaya İshak Çetin Özener Gamze Akbaş The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy Southern Clinics of Istanbul Eurasia c4d pla2r; primary membranous nephropathy; proteinuria. |
author_facet |
Deniz Filinte Hakkı Arıkan Mehmet Koç Handan Kaya İshak Çetin Özener Gamze Akbaş |
author_sort |
Deniz Filinte |
title |
The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy |
title_short |
The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy |
title_full |
The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy |
title_fullStr |
The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy |
title_full_unstemmed |
The Intensity of PLA2R and C4d Immunoexpression in Primary Membranous Nephropathy |
title_sort |
intensity of pla2r and c4d immunoexpression in primary membranous nephropathy |
publisher |
KARE Publishing |
series |
Southern Clinics of Istanbul Eurasia |
issn |
2587-0998 |
publishDate |
2020-06-01 |
description |
INTRODUCTION[|]Antibodies against the phospholipase A2 receptor (PLA2R) on podocyte membranes result in the formation of immune complexes that cause loss of function of the glomerular basement membrane in primary membranous nephropathy (PMN). It has also been demonstrated that there is a deposition of complement 4d (C4d) in the glomeruli in PMN. The present study aims to evaluate PLA2R and C4d immunoexpressions in PMN cases and search the correlation with the clinical parameters.[¤]METHODS[|]In this study, clinicopathological data and paraffin-embedded specimens were collected from 51 patients. The formalin-fixed paraffin-embedded tissues were stained using routine hematoxylin-eosin, periodic acid-Schiff, and silver methenamine stains and immunostained for anti-PLA2R and C4d. Ten normal kidney tissues and 10 focal segmental glomerulosclerosis (FSGS) cases were selected as controls for PLA2R and C4d immunoexpression.[¤]RESULTS[|]Of the PMN cases, 51 (100%) cases were positive for PLA2R, including 15 (29%) cases that scored 2+, and 36 (71%) cases that scored 3+. Forty of the 51 cases (78%) were positive for C4d. The percentages of cases staining positively for C4d, per scoring group, were as follows: 31 (61%) cases faintly (1+) positive and 9 (18%) cases moderately (2+) positive. No strong positivity was observed. All of the control cases (100%) were negative for PLA2R and C4d. There was no statistically significant difference between the intensity of the staining of PLA2R and the staining of C4d, proteinuria levels, creatinine levels, and complement 3 (C3) positivity. Similarly, there was no statistically significant difference between the intensity of the staining of C4d and proteinuria levels, creatinine levels, and C3 positivity.
[¤]DISCUSSION AND CONCLUSION[|]Immunohistochemical detection of PLA2R and C4d is a safe and easy method for the diagnosis of PMN. In cases where fresh tissue is not available for the detection of IgG and C3 using the immunofluorescence method, positivity for PLA2R and C4d with immunohistochemistry may be beneficial for the diagnosis of PMN.[¤] |
topic |
c4d pla2r; primary membranous nephropathy; proteinuria. |
url |
https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-16056 |
work_keys_str_mv |
AT denizfilinte theintensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT hakkıarıkan theintensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT mehmetkoc theintensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT handankaya theintensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT ishakcetinozener theintensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT gamzeakbas theintensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT denizfilinte intensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT hakkıarıkan intensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT mehmetkoc intensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT handankaya intensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT ishakcetinozener intensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy AT gamzeakbas intensityofpla2randc4dimmunoexpressioninprimarymembranousnephropathy |
_version_ |
1724325167898820608 |